Literature DB >> 2580939

Obligatory role of gamma interferon in T cell-replacing factor-dependent, antigen-specific murine B cell responses.

M Brunswick, P Lake.   

Abstract

The role of gamma interferon (IFN-gamma) in T cell-replacing factor (TRF) activity for antigen-specific plaque-forming cell (PFC) responses in vitro was studied using antibodies to murine IFN-gamma (Mu IFN-gamma). TRF activity was present in supernatants (Sn) of Con A- or mixed leukocyte reaction-stimulated murine spleen cells as well as in an IL-2-rich fraction of phytohemagglutinin-stimulated human peripheral blood lymphocyte Sn and in the Sn of the Gibbon T lymphoma MLA-144. The human TRF was highly active with cells from nu/nu mice and normal mice but not with cells from animals with the xid immunologic defect, similar to the activity of murine TRF. Antibodies to IFN-gamma consisted of hyper-immune rabbit antisera, IFN-gamma affinity-purified rabbit immunoglobulin and an interspecies hybridoma specific for Mu IFN-gamma. The results show that the activities of all preparations of TRF are markedly diminished or abrogated by antibody to Mu IFN-gamma but not by antibodies to human IFN-gamma (Hu IFN-gamma), nor by normal rabbit sera or purified rabbit Ig. The degree of inhibition was dose dependent and was quantitatively reversed by the addition to the cultures of recombinant-derived Mu IFN-gamma (Mu rIFN-gamma) but not Hu rIFN-gamma. This reversal was fully antigen specific and thus not attributable to polyclonal B cell activation by IFN-gamma, which is inactive alone in the TRF assay. Kinetic analysis shows that IFN-gamma must act by 24-48 h to produce PFC responses at 4 d. Together, the data demonstrate that IFN-gamma is a necessary mediator for TRF effects and that IFN-gamma is induced by TRF from T-depleted murine spleen cells in sufficient quantity to support large antibody responses. The source of this IFN-gamma may be the potent natural killer cells that are induced in cultures stimulated with TRF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580939      PMCID: PMC2187618          DOI: 10.1084/jem.161.5.953

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

Review 1.  A third signal in B cell activation given by TRF.

Authors:  A Schimpl; E Wecker
Journal:  Transplant Rev       Date:  1975

2.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

3.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

4.  Production of Con A-induced helper T cell replacing factor requires a T cell and an Ia-positive non-T cells.

Authors:  S L Swain; R W Dutton
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

Review 5.  Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells.

Authors:  D C Parker
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  The xenogeneic effect. I. Antigen and mitogen-stimulated human lymphocytes produce a non-antigen-specific factor which reconstitutes the antibody response of T cell-deficient mouse spleen cells.

Authors:  J J Farrar
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

7.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  Biochemical relationship between murine immune interferon and a killer cell helper factor.

Authors:  P L Simon; J J Farrar; P D Dind
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

9.  Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen.

Authors:  S L Swain; G Dennert; J F Warner; R W Dutton
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes.

Authors:  S Gillis; N A Union; P E Baker; K A Smith
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  7 in total

1.  Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis.

Authors:  G F Del Prete; A Tiri; S Mariotti; A Pinchera; M Ricci; S Romagnani
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

2.  Roles of IL-2 and antigen in the later stages of the primary antibody response.

Authors:  J Sawada; T Terao; M A Leon
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Cytokine regulation of murine leishmaniasis: interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice.

Authors:  M D Sadick; N Street; T R Mosmann; R M Locksley
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Differential cytokine production associated with distinct phases of murine graft-versus-host reaction.

Authors:  P Garside; S Reid; M Steel; A M Mowat
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

5.  Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.

Authors:  J L Madara; J Stafford
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

6.  Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice.

Authors:  F D Finkelman; A Svetic; I Gresser; C Snapper; J Holmes; P P Trotta; I M Katona; W C Gause
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

Review 7.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.